The HCG Institute Review

What The HCG Institute charges

• Sermorelin: $269/mo — "Sermorelin Injections $269.00 ... Monthly Program: One 9mg or 15mg vial of Sermorelin." The program selector prints uplifts on that base: "Three Month Program - 9mg +$526.00 / One Month Program - 15mg +$100.00 / Three Month Program - 15mg +$726.00". Same page: "Unavailable in: MS" and "Must start with 9mg vial unless previously prescribed a higher dose"
• NAD+: $395 — "NAD+ Injections $395.00 ... Requires overnight shipping and must be refrigerated upon arrival. Unavailable in: MS" — no supply period and no strength stated. ⛔ The catalogue separately prices an "Ultra SermorLean - Sermorelin, Naltrexone, Ultra Lipotropic 10" at the same $395.00, which is a three-ingredient combination and not this compound
• Glutathione: $179 — "Glutathione Injections $179.00" in the storefront catalogue, with no supply period stated. The same catalogue prices two other preparations of the compound: "Glutathione Suppositories $199.00" and "Glutathione Troches $229.00"
• Glutathione: $229 — "Glutathione Troches $229.00" in the storefront catalogue, with no supply period stated — the most expensive of this seller’s three preparations of the compound
• PT-141: $329 — "PT-141 Bremelanotide Injections $329.00" in the storefront catalogue, with no supply period stated

The pages named for compounds are not where the prices are

This host publishes a long run of pages whose addresses are compound names, and several more that begin with the word buy.

Between them they carry no purchase figure at all; they are explanatory and comparative articles.

The prices live in a separate storefront tree, which runs on a different stack and has its own not-found page.

Every figure recorded here came from that storefront, and controls were fired at both trees so that the difference between them was tested rather than assumed.

Uplifts, not divisions

The programme selector on the priced compound page lists a base option and three others, each shown as an amount added to the base.

That is the opposite of the common pattern here, where a longer plan is quoted as a lower per-month rate the seller has computed by dividing a prepaid total.

Printing the difference rather than a divided rate means nothing on the page is a number nobody is charged.

This record stores the base figure and keeps the three uplifts in the qualifier exactly as printed, because adding them would publish totals the seller never prints.

A list price on everything, a supply period on almost nothing

The catalogue publishes a figure against every item it sells, which is more than most sellers here manage.

Only the growth-hormone compound states what a programme buys, naming the vial count for a monthly and a three-month course.

The other priced items compared here state no supply period and no strength, so their figures are recorded as non-monthly with that absence noted.

Two further preparations of one compound are priced separately in the same catalogue, and both are recorded rather than flattened into one.

Nationwide, except one state, and no pharmacy named

The store header says the seller serves patients nationwide by telemedicine, and the product pages name a single state where the products are unavailable.

Nationwide is not a count, and subtracting one exclusion from fifty to publish a roster would be arithmetic the seller has not done, so this row stores no states and keeps the exclusion beside the figures.

The pages describe compounding by state-regulated pharmacies and shipping direct from a compounding pharmacy, without naming a facility.

The same disclaimer says the company does not manufacture, compound or dispense anything itself, which makes the unnamed facility the party that actually fills the order.

FDA disclosure

The HCG Institute received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Read the compound-named editorial pages first and confirmed they carry no purchase figure, then found the storefront where the prices actually are.
• Fired nonsense paths at both of this seller's document trees in the same pass and confirmed each returns its own genuine not-found document, since the two run on different stacks.
• Took every figure from the storefront catalogue or from the storefront product page for that item.
• Recorded the programme selector's longer options as uplifts printed on the base figure, and stored the base rather than any sum.
• Declined to add the uplifts to the base, because doing so would publish totals the seller never prints.
• Recorded the supply period only where the seller states one, and marked the other items as having none.
• Recorded the separate preparations of one compound as separate rows at their own figures.
• Read the coverage line and the product-level exclusion together, and stored no state list rather than subtracting one from fifty.
• Read the itemised list of what a purchase includes and confirmed lab work is not on it, then separated that from a monitoring sentence elsewhere on the page which is clinical advice rather than a billing statement.
• Screened this seller in the live federal warning-letter record with a known-good positive control and a nonsense negative control in the same run, then opened the one matching letter and confirmed it names this seller's own domain before attaching it.